An ABC News story cites a new review questioning behavioral therapy as an effective treatment for premature ejaculation. Dr. Stanley Althof, co-author of “The Cochrane Review,” which looked at four previous studies, says people are helped by psychotherapy but that “the studies didn't meet the bar for evidence-based research that's set very high these days," and that “We just have to be more rigorous in how we go about conducting research.”

In 90 percent of cases, ABC says, psychological factors come into play and therapy does help deal with stress and feelings of inadequacy. There are no FDA-approved medications for PE, so “doctors are forced to prescribe drugs off-label and monitor patients closely for possible side effects.”

But wait! About that lack of FDA-approved medication for PE? In an accompanying video interview, Dr. Hilda Hutcherson, author and professor at Columbia University’s College of Physicians and Surgeons, talks about a new spray for PE being tested in Europe. Dr. Hutcherson says PE is the most common male sexual dysfunction problem and is defined as ejaculation one minute or less into intercourse on a regular basis (the average man lasts 3-5 minutes).

The spray involves two local anesthetics and can make intercourse last about six times longer for the user when sprayed on five minutes before having sex. Dr. Huterson also says that the spray is in phase three of clinical trials so it could have FDA approval within a year.

Sheesh— can’t it come any quicker?